Ceredex Value Advisors LLC Invests $22.05 Million in BWX Technologies, Inc. $BWXT

Key Points

• Ceredex Value Advisors initiated a $22.05 million position in BWX Technologies, purchasing 113,300 shares, while institutional investors collectively own 94.39% of the company.
• Analysts maintain a generally positive outlook, with the stock holding a “Moderate Buy” consensus rating and an average price target of $227.20, despite some target reductions and hold ratings.
• BWXT exceeded quarterly EPS expectations and reported 18% year-over-year revenue growth. The company also declared a quarterly dividend of $0.27 per share, equal to a 0.7% annualized yield.

Ceredex Value Advisors LLC bought a new stake in BWX Technologies, Inc. (NYSE:BWXT - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 113,300 shares of the technology company's stock, valued at approximately $22,054,000. Ceredex Value Advisors LLC owned about 0.12% of BWX Technologies at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of BWXT. MV Capital Management Inc. purchased a new stake in shares of BWX Technologies during the fourth quarter valued at approximately $32,000. WFA of San Diego LLC bought a new stake in BWX Technologies during the 2nd quarter valued at $29,000. Tucker Asset Management LLC bought a new stake in BWX Technologies during the 4th quarter valued at $36,000. Vermillion Wealth Management Inc. boosted its position in BWX Technologies by 71.7% during the 4th quarter. Vermillion Wealth Management Inc. now owns 237 shares of the technology company's stock valued at $41,000 after buying an additional 99 shares during the period. Finally, Smithfield Trust Co boosted its position in BWX Technologies by 52.1% during the 4th quarter. Smithfield Trust Co now owns 251 shares of the technology company's stock valued at $44,000 after buying an additional 86 shares during the period. 94.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on BWXT shares. Truist Financial decreased their price objective on shares of BWX Technologies from $212.00 to $202.00 and set a "hold" rating on the stock in a research report on Friday, August 14th. BTIG Research reiterated a "buy" rating and set a $235.00 target price on shares of BWX Technologies in a report on Tuesday, August 4th. Zacks Research cut BWX Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 11th. JPMorgan Chase & Co. assumed coverage on BWX Technologies in a report on Monday, July 27th. They set an "overweight" rating and a $230.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft raised BWX Technologies from a "hold" rating to a "buy" rating and upped their price target for the company from $205.00 to $255.00 in a research report on Friday, May 15th. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $227.20.

Insider Buying and Selling

In other news, CEO Rex D. Geveden sold 10,000 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $172.50, for a total value of $1,725,000.00. Following the sale, the chief executive officer directly owned 192,491 shares of the company's stock, valued at approximately $33,204,697.50. This represents a 4.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company's stock.

BWX Technologies Price Performance

Shares of NYSE BWXT opened at $156.71 on Friday. The company has a 50 day simple moving average of $181.44 and a two-hundred day simple moving average of $197.69. BWX Technologies, Inc. has a fifty-two week low of $154.59 and a fifty-two week high of $241.82. The company has a market capitalization of $14.36 billion, a price-to-earnings ratio of 40.60, a P/E/G ratio of 2.54 and a beta of 0.76. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.33 and a current ratio of 2.40.

BWX Technologies (NYSE:BWXT - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The technology company reported $1.07 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.03. The firm had revenue of $901.62 million for the quarter, compared to analysts' expectations of $902.41 million. BWX Technologies had a return on equity of 30.83% and a net margin of 10.11%.The business's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.02 EPS. BWX Technologies has set its FY 2026 guidance at 4.700-4.800 EPS. Analysts expect that BWX Technologies, Inc. will post 4.75 EPS for the current fiscal year.

BWX Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Tuesday, August 18th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, August 18th. BWX Technologies's payout ratio is 27.98%.

About BWX Technologies

BWX Technologies, Inc NYSE: BWXT is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company's core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source